COMP <GO>
ANIK vs PROF // NET PROFIT MARGIN
Anika Therapeutics Inc. (NASDAQ) VS. Profound Medical Corp. (NASDAQ) • 15-METRIC TALLY: ANIK 6
— PROF 3
▲ NET PROFIT MARGIN LEADER: ANIK
LAST: $19.41 (-7.35%) • MKT CAP: $280.4M
net-margins
-9.80%
LAST: $6.73 (+2.44%) • MKT CAP: $240.0M
net-margins
-60.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ANIK VS. PROF)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ANIK | PROF | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 56.60% | 70.80% | -14.20 | PROF | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -10.20% | -35.00% | +24.80 | ANIK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 1.50% | -17.93% | +19.43 | ANIK | /fcf-yield <GO> |
| Operating Margin | -9.80% | -60.00% | +50.20 | ANIK | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -9.80% | -60.00% | +50.20 | ANIK | /net-margins <GO> |
| Revenue Growth (YoY) | -5.90% | 65.30% | -71.20 | PROF | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 5.97 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 5/9 | +1.00 | ANIK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.8 | 56.4 | -4.60 | PROF | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $280.4M | $240.0M | $40.4M | ANIK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ANIK REV | PROF REV | ANIK GROSS % | PROF GROSS % | ANIK FCF | PROF FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $112.8M | $16.1M | 56.6% | 70.8% | $4.4M | -$38.4M |
| FY 2024 | $119.9M | $9.7M | 63.4% | 72.2% | -$2.3M | -$23.5M |
| FY 2023 | $120.8M | $5.9M | — | — | -$1.8M | -$22.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ANIK // BETA —
PROF // BETA —